CUAMC
ZBIO

China Universal Asset Management Company’s Zenas BioPharma ZBIO Stock Holding History

China Universal Asset Management Company’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$478K Buy
18,848
+5,322
+39% +$106K 0.03% 270
2026
Q1 		$264K Buy
13,526
+212
+2% +$4.76K 0.02% 328
2025
Q4 		$483K Buy
+13,314
New +$438K 0.04% 260

Other funds holding ZBIO

IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

China Universal Asset Management Company's ZBIO Position: Q2 2026 in Review

China Universal Asset Management Company increased its Zenas BioPharma (ZBIO) stake by 39% in Q2 2026, buying an estimated $106K and bringing the position to 18,848 shares worth $478K. The position accounts for 0.03% of the portfolio, ranked #270.

China Universal Asset Management Company first reported a position in ZBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $483K in Q4 2025. 17 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • China Universal Asset Management Company held 18,848 shares of Zenas BioPharma worth $478K as of Q2 2026.
  • China Universal Asset Management Company bought 5,322 Zenas BioPharma shares in Q2 2026, an estimated $106K.
  • Zenas BioPharma made up 0.03% of China Universal Asset Management Company's portfolio in Q2 2026, its #270 holding.
  • China Universal Asset Management Company first reported a position in Zenas BioPharma in Q4 2025 and has held it in 3 quarters since.
  • China Universal Asset Management Company's Zenas BioPharma position peaked at $483K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.